Whoa, Cuprina is a wild one! From maggots to IVF, this IPO is throwing every biotech idea at the wall. 🧪 But the chart is a horror show—a catastrophic drop from $9 to under a buck on insane volume. RSI is buried in the oversold basement. This looks like a classic "buy the rumor, sell the news" event that went nuclear. Until this finds a bottom, it's a hard SELL. The story is fascinating, but the stock is broken. #TrainWreck

**Hot Take:** Cuprina’s going full mad scientist—maggots, leeches, IVF labs, *and* an IPO? 🧪🚀 The stock’s been on a wild ride: RSI crashed from *"party mode"* (77) to *"fire sale"* (18) after that **bonkers** drop from $9.50 to $0.85 in a day. Volume spiked like a caffeine overdose, but the 9-period WMA nosedived below the 21—uh-oh. News is *wildly* bullish long-term, but short-term? Smells like a **"hold and watch"** until the dust settles. #BiotechChaos

Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CUPR: 0.6465 USD

Bullish views

Bearish views